Amantadine Hydrochloride
Who holds supplier records for Amantadine Hydrochloride? 5 organisations hold a current record for Amantadine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (1), Spain (1), Latvia (1), China (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Amantadine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/amantadine-hydrochloride
Reading the evidence
- 5 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (5)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Amantadine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 41517 · latest filing Mar 2025
- MOEHS IBERICA SLSpainCEPActive DMF 6924 · latest filing Apr 1987
- OLPHA ASLatviaCEP Company GMP cert on recordActive DMF 23528 · latest filing Feb 2010
- Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 25151 · latest filing Jul 2011
- AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPAItalyActive DMF 29486 · latest filing Sept 2015
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Amantadine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. Jinhua | CN | CEP 2025-139 - Rev 00 Amantadine hydrochloride | May 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2025-168 - Rev 00 Amantadine hydrochloride, Crystalline | Apr 2026 | — |
| OLPHA AS Olaine | LV | CEP 2017-284 - Rev 03 Amantadine hydrochloride | Oct 2024 | Inspected Mar 2026 Latvia |
| Moehs Iberica S.L. Rubi | ES | R1-CEP 2000-014 - Rev 08 Amantadine hydrochloride | May 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Amantadine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- NORTHEAST GENERAL PHARMACEUTICAL FACTORYInactive DMF 9665 · filed Apr 1992
- CILAG CHEMIE AGInactive DMF 2817 · filed Jan 1977
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Amantadine Hydrochloride is used as both an antiviral and an antiparkinsonian drug. It is effective against influenza A virus infections and is also used to improve symptoms of Parkinson's disease.
Chemical identity
- IUPAC name
- adamantan-1-amine;hydrochloride
- Canonical SMILES
- C1C2CC3CC1CC(C2)(C3)N.Cl
- InChIKey
- WOLHOYHSEKDWQH-UHFFFAOYSA-N
- Synonyms
- Symmetrel API, amantadine hcl, exp-105-1, mantadix, nsc-83653, osmolex, symadine, symmetrel
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Influenza A M2 Protein Inhibitor
- Mechanism of action
- M2 Protein Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Amantadine Hydrochloride?
5 organisations hold an active US FDA Type II Drug Master File or a CEP for Amantadine Hydrochloride: Alembic Pharmaceuticals Limited (India), MOEHS IBERICA SL (Spain), OLPHA AS (Latvia), Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. (China) and AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Amantadine Hydrochloride Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 41517), MOEHS IBERICA SL (DMF 6924), OLPHA AS (DMF 23528), Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. (DMF 25151) and AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPA (DMF 29486). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Amantadine Hydrochloride records mean?
2 organisations have only inactive Type II DMFs for Amantadine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Amantadine Hydrochloride have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Amantadine Hydrochloride on the EDQM register, including ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. Jinhua (CN), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), OLPHA AS Olaine (LV) and Moehs Iberica S.L. Rubi (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Amantadine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Amantadine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.